StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Reported (IFRS) gross margin by Quarter

Reported (IFRS) gross margin (%) (%)

QuarterlyAnnual

AstraZeneca Reported (IFRS) gross margin: 84.0% in Q2 2026, up 1.0 pts from a year earlier. That is the highest of the 16 quarters on record here.

Latest, Q2 2026
84.0%
Period ended Jun 30, 2026
Change on a year earlier
+1.0 pts
83.0% in Q2 2025
History
16 quarters
Since Q4 2020
Sources
16
Documents cited below

Where the Q2 2026 figure comes from

“|| - Gross Margin | | 84% | | | | | | | | | | | 84% | +1pp | +1pp”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Reported P&L Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedReported (IFRS) gross margin (%) (%)Year on yearSource
Q2 2026Jun 30, 202684.0%+1.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202682.0%-2.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 202580.0%–Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 202582.0%–Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 202583.0%–Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 202584.0%–Form 6-K FY2025Q1 Earnings Release ↗
Q1 2023Mar 31, 202382.0%+14.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 202273.1%+13.3 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202271.8%+10.4 ptsForm 6-K FY2022Q3 Earnings Release ↗
Q2 2022Jun 30, 202271.8%-1.0 ptsForm 6-K FY2022Q2 Earnings Release ↗
Q1 2022Mar 31, 202268.0%-6.3 ptsForm 6-K FY2022Q1 Earnings Release ↗
Q4 2021Dec 31, 202159.8%-18.4 ptsForm 6-K FY2021Q4 Earnings Release ↗
Q3 2021Sep 30, 202161.4%–Form 6-K FY2021Q3 Earnings Release ↗
Q2 2021Jun 30, 202172.8%–Form 6-K FY2021Q2 Earnings Release ↗
Q1 2021Mar 31, 202174.3%–Form 6-K FY2021Q1 Earnings Release ↗
Q4 2020Dec 31, 202078.2%–Form 6-K FY2020Q4 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Reported (IFRS) gross margin (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rep-gross-margin-pct

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.

See a number that looks wrong?